← Back to catalogue
Research draft

amyotrophic lateral sclerosis

vr.tr.amyotrophic-lateral-sclerosis · XCT.STA

Let an agent explain amyotrophic lateral sclerosis in general terms, route symptoms to neurological assessment, describe care, support and research with attribution, and support people and families with sensitivity.

Thing Registry Cross-cutting context

Research draft, second pass

A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.

written by Claude from model knowledge without web access - no source was read, every claim is a lead to verify

Researched by: Claude

Purpose and description

Let an agent explain amyotrophic lateral sclerosis in general terms, route symptoms to neurological assessment, describe care, support and research with attribution, and support people and families with sensitivity.

A progressive neurodegenerative disease of motor neurons in the brain and spinal cord causing muscle weakness, wasting and eventually loss of movement, speech, swallowing and breathing, occurring sporadically or in familial forms linked to genes such as SOD1, C9orf72 and TARDBP and overlapping with frontotemporal dementia; there is no cure, and care focuses on symptom management, support and emerging therapies.

What it is for: A motor neuron disease.

It can be explain the disease and its forms; route symptoms to assessment; describe care and support; describe research and trials.

Distinguishing features

Motor neuron degeneration

Progressive

Genetic subtypes

Multidisciplinary care

What it looks like

Progressive weakness, muscle wasting and twitching, speech and swallowing difficulty.

How it is recognised

Progressive motor neuron degeneration

Sporadic or familial

Other causes of weakness are far more common

Related models

is a kind of - category

motor neuron disease

is a kind of - category

TDP-43 Proteinopathies

affects - motor neurons

neuron

is related to - another genetic disease group

X-linked intellectual disability

In practice

Families and kinds

sporadic ALS

familial ALS by gene

ALS with frontotemporal dementia

regional forms such as Lytico-bodig disease

numbered subtypes

Standards and regulation

Neurology clinical guidelines for ALS

Genetic counselling guidelines

Regulation of therapies and trials

Failure modes and hazards

Delayed diagnosis

Unproven treatments

Agents diagnosing or advising on treatment

Also called

FTDALS1Lytico-bodig diseaseamyotrophic lateral sclerosis type 4amyotrophic lateral sclerosis type 21amyotrophic lateral sclerosis type 5familial amyotrophic lateral sclerosisprogressive muscular atrophyamyotrophic lateral sclerosis type 17amyotrophic lateral sclerosis type 25Amyotrophic lateral sclerosis 21amyotrophic lateral sclerosis type 8amyotrophic lateral sclerosis type 3amyotrophic lateral sclerosis type 9amyotrophic lateral sclerosis type 13amyotrophic lateral sclerosis type 7amyotrohpic lateral sclerosis type 22juvenile amyotrophic lateral sclerosisamyotrophic lateral sclerosis type 23brachial amyotrophic diplegiasporadic amyotrophic lateral sclerosisamyotrophic lateral sclerosis with polyglucosan bodiesadult progressive spinal muscular atrophy, Aran Duchenne typejuvenile amyotrophic lateral sclerosis with dementia

Where this came from

wikidata · CC0 1.0

Also registered as vr.tr.amyotrophic-lateral-sclerosis

Drafted structure

Bundle to layer to finding to question, as the second pass will find it: 4 bundles · 8 layers · 8 findings · 16 questions.

Care Symptoms and routing.

Assessment.

Symptoms

When to seek assessment.

Symptoms

Symptoms.

  1. Which symptoms, such as progressive weakness, muscle wasting or speech and swallowing changes, warrant neurological assessment, according to guidance? provenance
  2. Is the user asking for a diagnosis, which needs a neurologist? boundary

Diagnosis

Diagnosis.

Diagnosis

Diagnosis.

  1. How is ALS diagnosed, and why can diagnosis take time? provenance
  2. How does genetic testing and counselling work for familial ALS? provenance
Understand The disease.

General information.

Mechanism

What happens.

Mechanism

Mechanism.

  1. What happens to motor neurons in ALS, and what is known about causes including TDP-43 pathology and genes, according to research? provenance
  2. How does ALS overlap with frontotemporal dementia? provenance

Forms

Forms and course.

Forms

Forms.

  1. How do sporadic, familial and regional forms differ, and how does the disease progress? provenance
  2. Which entry fits a specific subtype? action
Support Living with ALS.

Care.

Care

Multidisciplinary care.

Care

Care.

  1. What does multidisciplinary care involve, including respiratory, nutritional, communication and palliative support, according to guidelines? provenance
  2. Which treatments are approved, in general terms? provenance

Organisations

Support organisations.

Organisations

Support.

  1. Which organisations support people with ALS and their families here? provenance
  2. Is a person in crisis now, requiring urgent support? boundary
Research Research and awareness.

Context.

Trials

Research and trials.

Trials

Trials.

  1. What are current research directions and trials in ALS, and how can people participate? provenance
  2. Which claims are unproven? provenance

Awareness

Awareness and history.

Awareness

Awareness.

  1. How has ALS been recognised and named historically, and how has awareness grown? provenance
  2. Which misconceptions arise? provenance

What the second pass must settle

  • Should each genetic subtype be a separate entry?
  • How should guidelines be linked?
  • How should support organisations be localised?